Etoricoxib (arcoxia) in rheumatology
The paper gives information on the selective COX-2 inhibitor etoricoxib registered for use in many countries of the world. It gives a brief description of a few key trials of the efficacy and tolerability of etoricoxib in rheumatology
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Russo |
| Udgivet: |
IMA-PRESS LLC
2011-06-01
|
| Serier: | Современная ревматология |
| Fag: | |
| Online adgang: | http://mrj.ima-press.net/index.php/mrj/article/view/356 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|